Cargando…

Antibiotic treatment failure in children aged 1 to 59 months with World Health Organization-defined severe pneumonia in Malawi: A CPAP IMPACT trial secondary analysis

BACKGROUND: Pneumonia is a leading cause of mortality in children <5 years globally. Early identification of hospitalized children with pneumonia who may fail antibiotics could improve outcomes. We conducted a secondary analysis from the Malawi CPAP IMPACT trial evaluating risk factors for antibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mvalo, Tisungane, Smith, Andrew G., Eckerle, Michelle, Hosseinipour, Mina C., Kondowe, Davie, Vaidya, Dhananjay, Liu, Yisi, Corbett, Kelly, Nansongole, Dan, Mtimaukanena, Takondwa A., Lufesi, Norman, McCollum, Eric D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750006/
https://www.ncbi.nlm.nih.gov/pubmed/36516197
http://dx.doi.org/10.1371/journal.pone.0278938
_version_ 1784850154467098624
author Mvalo, Tisungane
Smith, Andrew G.
Eckerle, Michelle
Hosseinipour, Mina C.
Kondowe, Davie
Vaidya, Dhananjay
Liu, Yisi
Corbett, Kelly
Nansongole, Dan
Mtimaukanena, Takondwa A.
Lufesi, Norman
McCollum, Eric D.
author_facet Mvalo, Tisungane
Smith, Andrew G.
Eckerle, Michelle
Hosseinipour, Mina C.
Kondowe, Davie
Vaidya, Dhananjay
Liu, Yisi
Corbett, Kelly
Nansongole, Dan
Mtimaukanena, Takondwa A.
Lufesi, Norman
McCollum, Eric D.
author_sort Mvalo, Tisungane
collection PubMed
description BACKGROUND: Pneumonia is a leading cause of mortality in children <5 years globally. Early identification of hospitalized children with pneumonia who may fail antibiotics could improve outcomes. We conducted a secondary analysis from the Malawi CPAP IMPACT trial evaluating risk factors for antibiotic failure among children hospitalized with pneumonia. METHODS: Participants were 1–59 months old with World Health Organization-defined severe pneumonia and hypoxemia, severe malnutrition, and/or HIV exposure/infection. All participants received intravenous antibiotics per standard care. First-line antibiotics were benzylpenicillin and gentamicin for five days. Study staff assessed patients for first-line antibiotic failure daily between days 3–6. When identified, patients failing antibiotics were switched to second-line ceftriaxone. Analyses excluded children receiving ceftriaxone and/or deceased by hospital day two. We compared characteristics between patients with and without treatment failure and fit multivariable logistic regression models to evaluate associations between treatment failure and admission characteristics. RESULTS: From June 2015–March 2018, 644 children were enrolled and 538 analyzed. Antibiotic failure was identified in 251 (46.7%) participants, and 19/251 (7.6%) died. Treatment failure occurred more frequently with severe malnutrition (50.2% (126/251) vs 28.2% (81/287), p<0.001) and amongst those dwelling ≥10km from a health facility (22.3% (56/251) vs 15.3% (44/287), p = 0.026). Severe malnutrition occurred more frequently among children living ≥10km from a health facility than those living <10km (49.0% (49/100) vs 35.7% (275/428), p = 0.014). Children with severe malnutrition (adjusted odds ratio (aOR) 2.2 (95% CI 1.52, 3.24), p<0.001) and pre-hospital antibiotics ((aOR 1.47, 95% CI 1.01, 2.14), p = 0.043) had an elevated aOR for antibiotic treatment failure. CONCLUSION: Severe malnutrition and pre-hospital antibiotic use predicted antibiotic treatment failure in this high-risk severe pneumonia pediatric population in Malawi. Our findings suggest addressing complex sociomedical conditions like severe malnutrition and improving pneumonia etiology diagnostics will be key for better targeting interventions to improve childhood pneumonia outcomes.
format Online
Article
Text
id pubmed-9750006
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-97500062022-12-15 Antibiotic treatment failure in children aged 1 to 59 months with World Health Organization-defined severe pneumonia in Malawi: A CPAP IMPACT trial secondary analysis Mvalo, Tisungane Smith, Andrew G. Eckerle, Michelle Hosseinipour, Mina C. Kondowe, Davie Vaidya, Dhananjay Liu, Yisi Corbett, Kelly Nansongole, Dan Mtimaukanena, Takondwa A. Lufesi, Norman McCollum, Eric D. PLoS One Research Article BACKGROUND: Pneumonia is a leading cause of mortality in children <5 years globally. Early identification of hospitalized children with pneumonia who may fail antibiotics could improve outcomes. We conducted a secondary analysis from the Malawi CPAP IMPACT trial evaluating risk factors for antibiotic failure among children hospitalized with pneumonia. METHODS: Participants were 1–59 months old with World Health Organization-defined severe pneumonia and hypoxemia, severe malnutrition, and/or HIV exposure/infection. All participants received intravenous antibiotics per standard care. First-line antibiotics were benzylpenicillin and gentamicin for five days. Study staff assessed patients for first-line antibiotic failure daily between days 3–6. When identified, patients failing antibiotics were switched to second-line ceftriaxone. Analyses excluded children receiving ceftriaxone and/or deceased by hospital day two. We compared characteristics between patients with and without treatment failure and fit multivariable logistic regression models to evaluate associations between treatment failure and admission characteristics. RESULTS: From June 2015–March 2018, 644 children were enrolled and 538 analyzed. Antibiotic failure was identified in 251 (46.7%) participants, and 19/251 (7.6%) died. Treatment failure occurred more frequently with severe malnutrition (50.2% (126/251) vs 28.2% (81/287), p<0.001) and amongst those dwelling ≥10km from a health facility (22.3% (56/251) vs 15.3% (44/287), p = 0.026). Severe malnutrition occurred more frequently among children living ≥10km from a health facility than those living <10km (49.0% (49/100) vs 35.7% (275/428), p = 0.014). Children with severe malnutrition (adjusted odds ratio (aOR) 2.2 (95% CI 1.52, 3.24), p<0.001) and pre-hospital antibiotics ((aOR 1.47, 95% CI 1.01, 2.14), p = 0.043) had an elevated aOR for antibiotic treatment failure. CONCLUSION: Severe malnutrition and pre-hospital antibiotic use predicted antibiotic treatment failure in this high-risk severe pneumonia pediatric population in Malawi. Our findings suggest addressing complex sociomedical conditions like severe malnutrition and improving pneumonia etiology diagnostics will be key for better targeting interventions to improve childhood pneumonia outcomes. Public Library of Science 2022-12-14 /pmc/articles/PMC9750006/ /pubmed/36516197 http://dx.doi.org/10.1371/journal.pone.0278938 Text en © 2022 Mvalo et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Mvalo, Tisungane
Smith, Andrew G.
Eckerle, Michelle
Hosseinipour, Mina C.
Kondowe, Davie
Vaidya, Dhananjay
Liu, Yisi
Corbett, Kelly
Nansongole, Dan
Mtimaukanena, Takondwa A.
Lufesi, Norman
McCollum, Eric D.
Antibiotic treatment failure in children aged 1 to 59 months with World Health Organization-defined severe pneumonia in Malawi: A CPAP IMPACT trial secondary analysis
title Antibiotic treatment failure in children aged 1 to 59 months with World Health Organization-defined severe pneumonia in Malawi: A CPAP IMPACT trial secondary analysis
title_full Antibiotic treatment failure in children aged 1 to 59 months with World Health Organization-defined severe pneumonia in Malawi: A CPAP IMPACT trial secondary analysis
title_fullStr Antibiotic treatment failure in children aged 1 to 59 months with World Health Organization-defined severe pneumonia in Malawi: A CPAP IMPACT trial secondary analysis
title_full_unstemmed Antibiotic treatment failure in children aged 1 to 59 months with World Health Organization-defined severe pneumonia in Malawi: A CPAP IMPACT trial secondary analysis
title_short Antibiotic treatment failure in children aged 1 to 59 months with World Health Organization-defined severe pneumonia in Malawi: A CPAP IMPACT trial secondary analysis
title_sort antibiotic treatment failure in children aged 1 to 59 months with world health organization-defined severe pneumonia in malawi: a cpap impact trial secondary analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750006/
https://www.ncbi.nlm.nih.gov/pubmed/36516197
http://dx.doi.org/10.1371/journal.pone.0278938
work_keys_str_mv AT mvalotisungane antibiotictreatmentfailureinchildrenaged1to59monthswithworldhealthorganizationdefinedseverepneumoniainmalawiacpapimpacttrialsecondaryanalysis
AT smithandrewg antibiotictreatmentfailureinchildrenaged1to59monthswithworldhealthorganizationdefinedseverepneumoniainmalawiacpapimpacttrialsecondaryanalysis
AT eckerlemichelle antibiotictreatmentfailureinchildrenaged1to59monthswithworldhealthorganizationdefinedseverepneumoniainmalawiacpapimpacttrialsecondaryanalysis
AT hosseinipourminac antibiotictreatmentfailureinchildrenaged1to59monthswithworldhealthorganizationdefinedseverepneumoniainmalawiacpapimpacttrialsecondaryanalysis
AT kondowedavie antibiotictreatmentfailureinchildrenaged1to59monthswithworldhealthorganizationdefinedseverepneumoniainmalawiacpapimpacttrialsecondaryanalysis
AT vaidyadhananjay antibiotictreatmentfailureinchildrenaged1to59monthswithworldhealthorganizationdefinedseverepneumoniainmalawiacpapimpacttrialsecondaryanalysis
AT liuyisi antibiotictreatmentfailureinchildrenaged1to59monthswithworldhealthorganizationdefinedseverepneumoniainmalawiacpapimpacttrialsecondaryanalysis
AT corbettkelly antibiotictreatmentfailureinchildrenaged1to59monthswithworldhealthorganizationdefinedseverepneumoniainmalawiacpapimpacttrialsecondaryanalysis
AT nansongoledan antibiotictreatmentfailureinchildrenaged1to59monthswithworldhealthorganizationdefinedseverepneumoniainmalawiacpapimpacttrialsecondaryanalysis
AT mtimaukanenatakondwaa antibiotictreatmentfailureinchildrenaged1to59monthswithworldhealthorganizationdefinedseverepneumoniainmalawiacpapimpacttrialsecondaryanalysis
AT lufesinorman antibiotictreatmentfailureinchildrenaged1to59monthswithworldhealthorganizationdefinedseverepneumoniainmalawiacpapimpacttrialsecondaryanalysis
AT mccollumericd antibiotictreatmentfailureinchildrenaged1to59monthswithworldhealthorganizationdefinedseverepneumoniainmalawiacpapimpacttrialsecondaryanalysis